Search research articles
Contact Us
Filters
Showing results (11-20 of 254) with videos related to
Page
of 26
Sort By:
JAMA Dermatology
|
October 11, 2023
Isotretinoin for Treatment of Acne
John S Barbieri
JAMA Dermatology
|
April 23, 2020
A New Class of Topical Acne Treatment Addressing the Hormonal Pathogenesis of Acne
John S Barbieri
The Journal of Investigative Dermatology
|
May 5, 2025
Challenges with Using the FDA Adverse Event Reporting System to Evaluate the Risk of Benzoyl Peroxide-Containing Products
John S Barbieri
Journal of the American Academy of Dermatology
|
July 20, 2020
Isotretinoin and risk of inflammatory bowel disease: More data to support lack of meaningful risk
John S Barbieri
Archives of Dermatological Research
|
August 4, 2023
Temporal trends and sociodemographic differences in face-to-face time spent with dermatologists, 2006-2016
Katie Roster, John S Barbieri
Cutis
|
October 11, 2023
From Breakouts to Bargains: Strategies for Patient-Centered, Cost-effective Acne Care
Ali Shields, John S Barbieri
JAMA Dermatology
|
December 1, 2021
Introducing JAMA Network Insights in JAMA Dermatology
John S Barbieri, Kanade Shinkai
Cutis
|
August 28, 2025
Spironolactone for Acne: Practical Strategies for Optimal Clinical Outcomes
Sherry Ershadi, John S Barbieri
JAMA Dermatology
|
November 16, 2022
The Climate Crisis Affects Us All
Misha Rosenbach, John S Barbieri
The British Journal of Dermatology
|
July 28, 2023
Effectiveness of spironolactone for women with acne vulgaris (SAFA) trial: a critically appraised topic
Ali Shields, John S Barbieri
Page
of 26
Search research articles
Search
Showing results (11-20 of 254) with videos related to
Sort By:
Page
of 26
JAMA Dermatology
|
October 11, 2023
Isotretinoin for Treatment of Acne
John S Barbieri
JAMA Dermatology
|
April 23, 2020
A New Class of Topical Acne Treatment Addressing the Hormonal Pathogenesis of Acne
John S Barbieri
The Journal of Investigative Dermatology
|
May 5, 2025
Challenges with Using the FDA Adverse Event Reporting System to Evaluate the Risk of Benzoyl Peroxide-Containing Products
John S Barbieri
Journal of the American Academy of Dermatology
|
July 20, 2020
Isotretinoin and risk of inflammatory bowel disease: More data to support lack of meaningful risk
John S Barbieri
Archives of Dermatological Research
|
August 4, 2023
Temporal trends and sociodemographic differences in face-to-face time spent with dermatologists, 2006-2016
Katie Roster, John S Barbieri
Cutis
|
October 11, 2023
From Breakouts to Bargains: Strategies for Patient-Centered, Cost-effective Acne Care
Ali Shields, John S Barbieri
JAMA Dermatology
|
December 1, 2021
Introducing JAMA Network Insights in JAMA Dermatology
John S Barbieri, Kanade Shinkai
Cutis
|
August 28, 2025
Spironolactone for Acne: Practical Strategies for Optimal Clinical Outcomes
Sherry Ershadi, John S Barbieri
JAMA Dermatology
|
November 16, 2022
The Climate Crisis Affects Us All
Misha Rosenbach, John S Barbieri
The British Journal of Dermatology
|
July 28, 2023
Effectiveness of spironolactone for women with acne vulgaris (SAFA) trial: a critically appraised topic
Ali Shields, John S Barbieri
Page
of 26